Equity · Healthcare
PODD
NASDAQInsulet (PODD)
The line runs 145.14 USD on 12 August through 148.99 USD on 23 October, on a scale from 130 to 160. Days the market did not trade hold the previous close, flat.
- Market cap
- 10.3B USD
- P/E (TTM)
- 24.3
- Revenue, year to Dec 2025
- 2.7B USD
- EPS, diluted, year to Dec 2025
- 3.48 USD
- 52-week range
- 130.50 USD – 346 USD
- Avg volume
- 73.1K
as of Oct 23, 2026
Have Insulet (PODD) insiders bought or sold shares recently?
In the 90 days to 10 Nov 2026, Insulet insiders reported 1 open-market purchase and no sales (SEC Form 4).
Form 4, 90 days to 10 Nov 2026, newest reported trade 21 Aug 2026
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 21 Aug 2026 | McEvoy AshleyPresident and CEO | Buy | 1,100 | 162K USD |
3 other filings in the window: grants, exercises, tax withholding and transfers, not trades
| Reported | Insider | Type | Shares | Value |
|---|---|---|---|---|
| 01 Oct 2026 | Pease FlaviaEVP & CFO | Tax withheld | 1,882 | 246K USD |
| 30 Sep 2026 | Huffines Robert LutherDirector | Award | 178 | 23K USD |
| 30 Sep 2026 | MAZELSKY JONATHAN JAYDirector | Award | 141 | 18K USD |
Which funds hold Insulet (PODD)?
0 of the 45 institutional funds we track reported a Insulet position for the quarter ended 30 Sep 2026; the latest of those filings landed 06 Nov 2026.
| Fund | Position | Shares | Value | Shares q/q |
|---|---|---|---|---|
| Fisher Asset Management | Exited |
Have members of Congress traded Insulet (PODD)?
The most recent congressional trade disclosed in Insulet is a sale by Gilbert Ray Cisneros, Jr. (house, CA), dated 18 Sep 2026.
STOCK Act disclosures
| Traded | Member | Type | Amount | Filed after |
|---|---|---|---|---|
| 18 Sep 2026 | Gilbert Ray Cisneros, Jr.house · Democrat–CA | Sale | 1K USD–15K USD | 24 days |
| 12 Jul 2023 | Daniel S. Goldmanhouse · Democrat–NY | Sale | 1K USD–15K USD | 32 days |
| 10 Apr 2023 | Daniel S. Goldmanhouse · Democrat–NY | Purchase | 1K USD–15K USD | 39 days |
What has been filed or recorded for Insulet (PODD)?
The filings we hold for Insulet, newest first: 6 quarterly earnings reports, 2 annual reports and 5 reported financial figures, the latest dated 30 Sep 2026. No next earnings date is announced in SEC filings yet.
| And | ||||
|---|---|---|---|---|
| 30 Sep 2026 | Quarterly earnings | Q3 2026 reported | EPS 2.03 USD | Revenue $842M |
| 30 Sep 2026 | Financials | Total assets | 3.4B USD | at period end |
| 30 Sep 2026 | Financials | Total equity | 1.6B USD | at period end |
| 30 Jun 2026 | Quarterly earnings | Q2 2026 reported | EPS 1.37 USD | Revenue $802M |
| 31 Mar 2026 | Quarterly earnings | Q1 2026 reported | EPS 1.30 USD | Revenue $762M |
| 31 Dec 2025 | Annual report | FY 2025 reported | EPS 3.48 USD | Revenue $2.71B |
| 31 Dec 2025 | Financials | Revenue | 2.7B USD | fiscal year |
| 31 Dec 2025 | Financials | Net income | 247.1M USD | fiscal year |
| 31 Dec 2025 | Financials | Diluted EPS | 3.48 USD | fiscal year |
| 30 Sep 2025 | Quarterly earnings | Q3 2025 reported | EPS 1.24 USD | Revenue $706M |
| 30 Jun 2025 | Quarterly earnings | Q2 2025 reported | EPS 0.32 USD | Revenue $649M |
| 31 Mar 2025 | Quarterly earnings | Q1 2025 reported | EPS 0.50 USD | Revenue $569M |
| 31 Dec 2024 | Annual report | FY 2024 reported | EPS 5.78 USD | Revenue $2.07B |
What do people ask about Insulet (PODD)?
What did Insulet shares close at?148.99
Insulet closed at 148.99 USD on 23 Oct 2026, up 0.63% on the close before. That is the end-of-day price from Finazon, not a live quote.
What is Insulet’s market cap?10.3B
Insulet is worth 10.3B USD by market value as of 23 Oct 2026, which is the share price times the shares on issue from its SEC filings.
What is Insulet’s P/E ratio?24.3
Insulet has a price-to-earnings ratio of 24.3, as of 23 Oct 2026: the share price divided by what the company earned per share over the last four reported quarters. A higher number means the market pays more for each dollar of earnings.
What is Insulet’s revenue?2.7B
Insulet reported revenue of 2.7B USD for the year ended 31 Dec 2025, as filed with the SEC. See Filings
Have Insulet insiders bought or sold shares recently?1 purchase
In the 90 days to 10 Nov 2026, Insulet insiders reported 1 open-market purchase and no sales (SEC Form 4). A further 3 filings were grants, awards, gifts or exercises rather than open-market trades. See Insiders
Which funds own Insulet?0 of 45
0 of the 45 funds we track reported a Insulet position for the quarter ended 30 Sep 2026, per their SEC Form 13F filings. The largest reported position was Fisher Asset Management. See Funds
Have members of Congress traded Insulet?3 trades
Yes. 3 trades in Insulet appear in the congressional disclosures we hold; the latest is a sale by Gilbert Ray Cisneros, Jr. (House, CA) dated 18 Sep 2026, filed 12 Oct 2026. Amounts are disclosed as ranges, and a filing can follow the trade by up to 45 days. See Congress
When did Insulet last report earnings?2.03
Insulet last reported earnings on 30 Sep 2026 for Q3 2026, with EPS of 2.03 USD; no next date is announced in SEC filings yet. See Filings
Answers are generated from the live figures on this page — Reddit crowd data, SEC filings and open company records — and update as the data does.
References
- Finazonprior-day close, indicative (IEX-derived, not the official close), some closes dollar-rounded at the source
- TradingViewthe price chart widget, drawn by TradingView from their own data
- SEC EDGARForm 4 filings (insider transactions)
- SEC EDGAR13F filings
- Wikimedia CommonsPortraits via Wikimedia Commons. Daniel S. Goldman: US House, Public domain; Gilbert Ray Cisneros, Jr.: United States Department of Defense, Public domain.
- House disclosuresU.S. House of Representatives financial disclosures
- SEC EDGARXBRL company facts, latest period ended 30 Sep 2026
- SEC EDGARreported earnings figures and scheduled report dates
- SEC EDGARValuation computed from SEC EDGAR filings